Page 67 - Ruchika Chitravanshi

Decriminalisation in Companies Act a move in the right direction? Explained

As government revisits all economic laws, decriminalisation experts have called for a calibrated approach to ensure we don't end with toothless legislations and maintain the standards

Coronavirus can survive for 28 days on banknotes, mobile screens: Study

So far, it had been widely believed that the virus could survive for up to three days on solid surfaces

Covid-19: Feluda test roll-out in a few weeks, says Harsh Vardhan

Emergency use of Covid-19 vaccines only after trial data

Govt may allow use of Covid vaccine in emergency situations: Harsh Vardhan

Warns of spike in cases during winter; China, UAE among the few countries have allowed such authorisation

Falling out of favour: Consultancies and law firms suggest IBC revamp

Investors feel IBC's promised twin benefits - a time-bound process and assurance of a clean slate - don't necessarily come through

Dr Reddy's asked to re-submit Russian vaccine phase-3 trial application

Health Secy says a vaccine should be available in first quarter of next year if everything goes according to plan

Nearly 500 mn doses of Covid-19 vaccine by July 2021, says Harsh Vardhan

He also said that the government was also keeping an eye on immunity data with regard to Covid-19 while finalising these plans

Coronavirus test kits get cheaper but labs yet to pass on benefit

In Delhi and the National Capital Region alone, the price for an RT-PCR test for Covid ranges between Rs 1,600 and Rs 2,400

India's Covid-19 death toll nears 100,000 eight months after first case

68 per cent of the deaths were concentrated in just five states

Covid-19: 8% super-spreaders account for 60% new infections, says study

The findings are part of a survey conducted by the Center For Disease Dynamics, Economics & Policy (CDDEP) along with governments of Tamil Nadu and Andhra Pradesh

Decoding Feluda: The test that detects Covid-19 quickly, cheaply and easily

Named after Detective Feluda, a character created by filmmaker and writer, Satyajit Ray, the test based on the CRISPR technology is easy to use, gives faster results at a lower cost

Govt decriminalises Companies Act to promote greater ease of doing business

The bill, passed on Saturday in the Lok Sabha, comes at a time when companies are reeling under stress due the coronavirus (Covid-19) pandemic

Regulatory compliance, FCRA challenges for policy think tanks in India

Having set up its India office in 2013, Brookings Institution's brief stint here raises a key question: Are foreign think tanks less enamoured by India?

ICMR exploring saliva-based tests to diagnose Covid-19: Harsh Vardhan

Vardhan also said that no significant or drastic mutations had been found in strains of SARS-CoV-2 in India till now

At 4.2 mn, India has most number of patients to recover from Covid-19

The national recovery rate has increased to nearly 80 per cent even though the country's total cases exceeded 5.3 million

Emergency use authorisation of drugs or vaccines: What, when, how

The US Food and Drug Administration had recently allowed the emergency use of convalescent plasma therapy for Covid treatment, besides existing drugs such as Remdisivir

Spike in Covid-19 cases bares gaps in Delhi, Mumbai critical care infra

Industry says govt makeshift facilities lie vacant as patients scramble for private hospital beds

India's Covid-19 tally nears 5 mn with one-fifth of total cases active

India took six months to reach the first million covid cases and it has gone from four to 4.9 million in 11 days

Would be happy to take first dose of Covid-19 vaccine: Harsh Vardhan

Vardhan assured that the vaccine would be first made available to those who needed it the most, irrespective of their paying capacity

Storm surge in cases puts India on long road from pandemic to endemic

Unsurprised by the rising numbers, epidemiologists are concerned about the virus reaching rural and tribal areas